Sat 3/28/2020 07:58 ET
DJIA21636.78878.454.06%TELCO159.703.312.07%GOLD1630.6020.551.26%Shanghai2772.207.210.26%
S&P 5002541.4785.653.37%BANKS314.0414.454.60%OIL21.840.763.48%BITCOIN6160.91258.144.19%
NASDAQ7502.38284.343.79%PHARM520.9210.472.01%US/EU1.110.000.01%Futures2519.1288.923.53%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Spectrum Pharmaceuticals - SPPI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SPPI
  
From: singhtelecom (Rep: 971)Date: 05/11/2018 04:15
Forum: Spectrum Pharmaceuticals - Msg #695Thread #674008635 (Rec: 0)
ROLONTIS® (eflapegrastim) Phase 3 data abstract to be released by American Society of Clinical Oncology (ASCO) followed by an oral presentation at Multinational Association of Supportive Care in Cancer (MASCC) in June 2018.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreSPPI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SPPI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.